Betamethasone 17-valerate ointment in a lanolin-free base.
D000287:Administration, Topical; D001623:Betamethasone / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003877:Dermatitis, Contact / Q000209:etiology / Q000517:prevention & control; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004485:Eczema / Q000188:drug therapy*; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D007809:Lanolin / Q000009:adverse effects; D009824:Ointments / Q000627:therapeutic use; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D013258:Steroids, Chlorinated / Q000627:therapeutic use; D014631:Valerates / Q000008:administration & dosage* / Q000627:therapeutic use
D003879:Dermatologic Agents; D009824:Ointments; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D013258:Steroids, Chlorinated; D014631:Valerates; D005446:Fluocinolone Acetonide; D007809:Lanolin; D001623:Betamethasone